Prime Medicine (PRME) Operating Expenses (2021 - 2026)

Prime Medicine has reported Operating Expenses for 6 years, with the latest figure at $51.5 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 4.34% year-over-year to $51.5 million; the trailing twelve-month figure through Mar 2026 stood at $210.6 million (changed 0.13% YoY), and the FY2025 full-year result was $213.0 million, up 3.67% from the prior year.
• Operating Expenses for Q1 2026 stood at $51.5 million, up from $49.4 million in the prior quarter.
• The five-year high for Operating Expenses was $68.0 million in Q4 2023, with the low at $19.9 million in Q1 2022.
• Historically, Operating Expenses has averaged $46.5 million across 5 years, with a median of $49.4 million in 2025.
• The largest YoY upside for Operating Expenses was 203.59% in 2022 against a maximum downside of 35.6% in 2022.
• Prime Medicine's Operating Expenses stood at $38.7 million in 2022, then surged by 75.89% to $68.0 million in 2023, then slumped by 31.8% to $46.4 million in 2024, then gained by 6.55% to $49.4 million in 2025, then climbed by 4.17% to $51.5 million in 2026.
• The last three Operating Expenses figures came in at $51.5 million (Q1 2026), $49.4 million (Q4 2025), and $55.2 million (Q3 2025), per Business Quant data.